Tag: big pharma

TrumpRx Is Obamacare in Trump’s Handwriting

This week, President Donald Trump announced the next in a long line of vanity projects: TrumpRX, a forthcoming, federally branded website where Pfizer sells steeply discounted drugs in exchange for a three-year exemption from his proposed 100 percent tariffs on imported pharmaceuticals. Imagine a strip mall furniture store with a permanent, flashy 70-percent-off sale, masking the fact that prices were inflated in the first place. TrumpRx, slated to launch in early 2026, is no different—a government-run platform that promises savings while hiding costs.

But this isn’t just another Trump-branded vanity project like the ill-fated Trump Steaks or Trump University. It’s a wild pivot in right-leaning political thought on health care, and it’s a gut punch for those who see where this road leads.

Flash back to 2016: Trump hammering the Affordable Care Act, calling it a “disaster” and suggesting that the government’s only role should be to ensure these companies have “plenty of money.” He was channeling what economists had long warned: Government-run health care distorts markets, creates perverse incentives, and collapses under its own weight. Now, the president is embracing the very heavy-handed tactics he once trashed.

Keep reading

Pfizer Strikes $70 Billion Deal with U.S. to Expand Its mRNA Empire, Lower Drug Prices

Today, Pfizer announced a “landmark agreement” with the Trump Administration. The press release promised lower drug costs and a revival of U.S. manufacturing. President Donald Trump touted that Pfizer would cut Medicaid drug prices for low-income Americans and sell new medicines at a “most-favored-nation” price — but only in exchange for tariff relief.

In reality, it appears to be a multi-billion dollar effort to entrench Pfizer’s failed gene-transfer platforms for decades to come.

The deal secures a $70 billion commitment to U.S. R&D — a down payment on Pfizer’s next wave of gene-based products:

  • Cancer “vaccines”
  • Obesity injections
  • Expanded vaccine portfolio (flu, RSV, bird flu, more)
  • Chronic disease biologics in inflammation & immunology

Pfizer itself spelled it out:

“With this agreement in place, Pfizer can fully focus on delivering the next generation of cures… in areas like oncology, obesity, vaccines, and inflammation and immunology.”

This comes after Pfizer’s COVID-19 gene-based products have already been linked to catastrophic injuries, deaths, and disabilities worldwide. Instead of scrutiny, the company is rewarded with protection and growth.

Keep reading

Trump’s Tylenol Cautions Are Just Common Sense

ot too long ago, the corporate media seemed interested in protecting Americans from potentially harmful medications, to the point of broadcasting fabricated stories about deadly ivermectin overdoses. Yet, with a different president in office, the media is now hard at work downplaying medication safety concerns brought up by the FDA. When it comes to acetaminophen, what can we believe?

To begin with, any medical professional who pretends not to understand the life-threatening dangers posed by Tylenol is lying to you. In my years spent training in the pediatric ICU, by far the most common — and most dangerous — overdoses we saw were of acetaminophen. If such ingestions are not treated very aggressively, with regular checking of blood Tylenol levels and continuous infusion of the liver-protecting antidote, serious injury and death can ensue. Every single ER and ICU doctor and nurse knows the Tylenol overdose protocol just as well as they know the stroke treatment or asthma attack protocols — these are common emergencies that medical staff regularly treat and train on.

Indeed, the data confirms Tylenol toxicity is the leading cause of acute liver failure in the country, while Tylenol overdoses cause tens of thousands of ER visits per annum, killing five hundred Americans yearly. That’s roughly 500 more Americans than are killed each year by ivermectin overdoses, by the way. So please, please think twice before posting reels of you downing acetaminophen in your handmaid outfits to stick it to bad orange man, ladies.

Does any of the above prove conclusively that Tylenol use in pregnancy is always dangerous? No. But think back to your or your loved one’s last pregnancy. Do you remember the long, long list of forbidden items? Pregnant moms aren’t even allowed to eat cold cuts, or medium rare steak. Why must expectant mothers chew shoe leather for 9 months? Have there been extensive randomized controlled studies of Swedish twins proving that second trimester salami is fatal? Of course not. But given that there’s a chance of undercooked meats carrying some germs, doctors play it safe and advise moms to avoid them. Now, consider that Tylenol kills significantly more people yearly than black forest ham — is it responsible for doctors to encourage pregnant moms to take it without good reason?

Keep reading

Trump Derangement Syndrome comes for heralded off-label autism treatment after president endorses

he medical establishment and mainstream media are uniting against the Trump administration’s re-purposing of an inexpensive drug to treat an epidemic, calling it “unproven,” not “backed by science,” “not a cure” and “shocking” to endorse, with The New York Times emphasizing no profit-driven drug company suggested it.

In President Trump’s first term, it was ivermectin and hydroxychloroquine to treat COVID-19. In his second, it’s prescription leucovorin to treat autism spectrum disorder.

Long used to treat chemotherapy side effects, leucovorin calcium tablets got approved last week by the Food and Drug Administration to treat “cerebral folate deficiency” (CFD), whose clinical symptoms include “global developmental delays with autistic features,” following its own “systematic analysis of literature” from 2009 through last year.

“Published case reports provided patient-level data on over 40 patients,” adult and child, with most of those given leucovorin treatment showing “substantial improvement of symptoms of CFD that would not be expected when compared to the natural history of CFD due to FOLR1 gene variants,” the Federal Register notice says.

Health and Human Services Secretary Robert F. Kennedy Jr. touted leucovorin to treat autism Monday with Trump and Centers for Medicare and Medicaid Services Administrator Mehmet Oz, but it was quickly overshadowed by the other autism-related recommendation that pregnant women limit their use of Tylenol, which prompted a new TikTok challenge.

Keep reading

Mount Sinai: Prenatal Acetaminophen Exposure Increases Risks of Autism and ADHD in Children, According to Analysis of 46 Global Studies

Amid growing concern over neurodevelopmental disorders, a recent study from Mount Sinai Hospital has reignited the debate surrounding acetaminophen, commonly known as paracetamol or Tylenol.

This analgesic, used by over 50% of pregnant women worldwide to relieve pain and fever, maybe linked to an increased risk of autism and attention deficit hyperactivity disorder (ADHD) in their children.

The report, published in August 2025 in the journal Environmental Health, analyzed 46 previous studies from international groups.

It applied the Navigation Guide methodology, a rigorous framework for evaluating environmental evidence. The findings show a consistent association: prenatal acetaminophen exposure increases the risk of autism by 19% (odds ratio 1.19) and ADHD by 26% (odds ratio 1.26).

Diddier Prada, MD, PhD, lead researcher at the Icahn School of Medicine at Mount Sinai, emphasized: “Our findings indicate that higher-quality studies are more likely to show a link between prenatal acetaminophen exposure and elevated risks of autism and ADHD.”

The analysis included 20 studies on ADHD, eight on autism, and 18 on other neurodevelopmental disorders. This is not an isolated finding. A 2019 Johns Hopkins study, based on umbilical cord blood samples from 996 children, found that high acetaminophen levels tripled the risk of autism (up to 3.62 times) and doubled the risk of ADHD (up to 2.86 times).

Researchers measured metabolites in blood at birth and followed the children for an average of 8.9 years. Another study, funded by the NIH in 2025, confirmed similar patterns: the middle third of exposure increased the risk of ADHD by 2.26 times and autism by 2.14 times.

These data come from cohorts such as the Boston Birth Cohort and the Nurses’ Health Study II. The underlying biology points to concerning mechanisms. Acetaminophen crosses the placental barrier and can induce oxidative stress, disrupt hormones, and cause epigenetic changes that interfere with fetal brain development. The risk appears heightened in the third trimester, when the brain develops rapidly.

In September 2025, the U.S. FDA responded with a letter to clinicians, initiating changes to product labels like Tylenol’s. It cited “accumulated evidence” of an association with autism and ADHD, recommending minimal doses and short-term use.

Keep reading

Joe Rogan Stunned by Liberal Pregnant Women Downing Tylenol to Own Trump: ‘This Science Came From Harvard’

People have often joked that if Trump said breathing air is good for you, liberals would start dying of suffocation. Now we know there is some real truth behind that.

As the Gateway Pundit has reported, once the Trump administration cautioned pregnant women from taking Tylenol, pregnant liberal women started going on the internet and downing Tylenol, even filming it, in some cases with disastrous results.

On a recent episode of his podcast, Joe Rogan commented on this, noting that this science has been backed up by Harvard.

The Daily Caller reports:

Podcast host Joe Rogan on “The Joe Rogan Experience” Friday called out pregnant women who have been filming themselves consuming Tylenol in objection to President Donald Trump’s administration’s recommendation not to do so.

TikTok users ingested large amounts of Tylenol to mock Trump and Health and Human Services Secretary Robert F. Kennedy Jr. after announcing the findings of an association between the use of acetaminophen by pregnant women and autism diagnoses in children. Rogan noted on his podcast that the Trump administration cited a Harvard study to support its findings.

“I’ve been fascinated by these videos of pregnant women taking Tylenol to show Trump that they don’t believe in what RFK Jr. is saying, that it’s somehow or another anti-science — when this science came from Harvard,” Rogan said. “That’s where the study came from. He’s not making things up. And these people are like on TikTok — they’re pregnant women taking Tylenol.”

Keep reading

SCOOP: Tylenol Maker Privately Admitted Evidence Was Getting ‘Heavy’ For Autism Risk In 2018

The pharmaceutical company behind Tylenol privately acknowledged the likelihood of an association between its drug in pregnancy and neurodevelopmental disorders like autism in children seven years ago, company documents obtained by the Daily Caller News Foundation show.

“The weight of the evidence is starting to feel heavy to me,” said Rachel Weinstein, U.S. director of epidemiology for Janssen, the pharmaceutical arm of Johnson & Johnson, in 2018. Johnson & Johnson marketed Tylenol at the time but in 2023 spun off its consumer products division into a separate company called Kenvue.

Legacy media headlines and vocal public health experts have dismissed the conclusion of President Donald Trump and Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. that Tylenol taken in pregnancy and early infancy has driven rises in autism. But one stakeholder has for years viewed the evidence as credible enough to act upon, at least privately: The makers of Tylenol.

Keep reading

Government Announcement on Autism Should Revive Lawsuits Over Tylenol: Attorneys

The federal government’s new warning that taking Tylenol during pregnancy may lead to autism should prompt the revival of lawsuits from mothers who allege Tylenol caused their children’s autism or attention-deficit/hyperactivity disorder (ADHD), attorneys for the families said in a new filing.

Federal officials on Sept. 22 moved to update labeling for Tylenol and other drugs containing acetaminophen, which are used for pain and fever relief. Regulators said that “the use of acetaminophen by pregnant women may be associated with an increased risk of … autism and ADHD in children.”

During a press conference announcing the moves, Food and Drug Commissioner Dr. Marty Makary quoted Dr. Andrea Baccarelli, a dean at the Harvard School of Public Health, who said in his expert opinion in the legal case that “there is a causal relationship” between in utero exposure to acetaminophen and neurodevelopmental disorders such as autism.

“Expert opinion that is sound enough to persuade every Senate-confirmed federal scientist easily clears Rule 702(d)’s bar,” the attorneys said in the filing on Wednesday, referring to a rule governing the use of expert witnesses in litigation.

“Reasonable scientists can continue to debate Dr. Baccarelli’s conclusions. But affirming a decision characterizing his approach as ‘junk science’ would pose grave separation of powers concerns,” the attorneys said. “The executive branch safeguards public health from dangerous pharmaceutical interventions. A decision holding that a jury may not hear the same expert evidence that the executive branch credited will badly damage the public trust required for the executive to take care that the public-health laws are faithfully executed.”

The lawsuits in question alleged that retailers and Kenvue, which makes Tylenol, failed to warn people that drugs containing acetaminophen could cause autism or ADHD. U.S. District Judge Denise Cote ruled in 2023 that Baccarelli and other experts offered by plaintiffs cherry-picked and misrepresented the results of studies. She later dismissed the cases.

Keep reading

HHS Resurfaces Old Tylenol Post Warning Pregnant Women NOT to Use Their Product

The Department of Health and Human Services (HHS) resurfaced an eight-year-old tweet from Tylenol’s account.

The timing is ominous: the administration is now aggressively pushing a narrative linking Tylenol (acetaminophen) use in pregnancy to autism in children.

Just days ago, President Trump sounded the alarm on the potential link between Tylenol use during pregnancy and skyrocketing autism rates in children – a connection that’s been buried by the deep state bureaucrats at the FDA for far too long.

As reported by Bloomberg, HHS reposted the circa 2017 message on its official X account, with the chilling tag “No caption needed.”

The resurfaced statement from Tylenol’s official account bluntly told a concerned user:

“We actually don’t recommend using any of our products while pregnant. Thank you for taking the time to voice your concerns today.”

According to PBS, “Kenvue said in a statement that ‘sound science clearly shows that taking acetaminophen does not cause autism.” The company pointed to scientific reviews by multiple government regulators worldwide, including those previously published by the FDA.”

However in 2019, Tylenol also openly admitted: “It’d be great to touch base real quick since we haven’t tested Tylenol to be used during pregnancy (and see what coupons we have for baby!)”

Keep reading

Leavitt Torpedoes CBS Reporter’s Autism ‘Confusion’ Attack

In a sharp exchange during today’s White House briefing, Press Secretary Karoline Leavitt dismantled CBS News senior White House correspondent Ed O’Keefe’s attempt to frame President Trump’s upcoming autism announcement as potentially misleading for pregnant women.

O’Keefe pressed: “There are reams of scientific research that suggest there’s no clear link between autism and acetaminophen usage… [this] has the potential to confuse women, especially pregnant women, about what to do.”

Leavitt fired back without missing a beat: “I think women, for many years, in fact, for decades, Ed, have been confused by the rapid increase in autism in this country, in the childhood epidemic, that chronic epidemic, disease epidemic that is plaguing America’s youth.”

“Women are confused about that and they want answers to that,” Leavitt added, further noting “I would encourage everyone in this room to… listen to what the president and his team of outsiders have to say about this.”

The back-and-forth comes ahead of Trump’s 4 p.m. ET remarks, where he’s expected to highlight a potential link between prenatal acetaminophen use (the active ingredient in Tylenol) and rising autism rates—a claim already drawing fire from medical experts and the drug’s manufacturer, who cite large-scale studies showing no causal connection.

Leavitt’s pivot refocused the narrative on the administration’s push for answers to what she called a “chronic disease epidemic,” urging reporters to approach the announcement with “critical thinking skills and open ears.”

Spot-on clapback—Leavitt turned a gotcha question into a masterclass in redirecting to the bigger picture.

Tylenol’s parent company earlier commented on the upcoming announcement, stating “We believe independent, sound science clearly shows that taking acetaminophen does not cause autism. We strongly disagree with any suggestion otherwise and are deeply concerned with the health risk that this poses for expecting mothers.”

Keep reading